TITLE

Cost-effectiveness estimates for antenatal HIV testing in the Netherlands

AUTHOR(S)
Rozenbaum, M. H.; Verweel, G.; Folkerts, D. K. F.; Dronkers, F.; Van den Hoek, J. A. R.; Hartwig, N. G.; de Groot, R.; Postma, M. J.
PUB. DATE
October 2008
SOURCE
International Journal of STD & AIDS;Oct2008, Vol. 19 Issue 10, p668
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This paper provides an estimation of the lifetime health-care cost of HIV-infected children and an update of the costeffectiveness of universal HIV-screening of pregnant women in Amsterdam (The Netherlands). During 2003-2005, we collected data concerning the prevalence of newly diagnosed HIV-infected pregnant women in Amsterdam. Also, data on resource utilization and HAART regimen for HIV-infected children was gathered from a national registry. Using Kaplan-Meier survival analysis, we estimated the life-expectancy of a vertically HIV-infected child at 19 years, with the corresponding lifetime health-care costs of €179,974. HIVscreening of pregnant women could prevent 2.4 HIV transmissions annually in Amsterdam, based on an estimated prevalence of nine yet undiagnosed HIV-positive pregnant women per 10,000 pregnancies. We show that universal HIV screening during pregnancy generates significant net cost savings and health benefits in most situations. Universal antenatal HIV screening is justified in Amsterdam from a health-economic point of view.
ACCESSION #
42734666

 

Related Articles

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Transmission of HIV-1 infection due to a fist fight. Emerson, C. R.; Quah, S. P. // International Journal of STD & AIDS;Feb2008, Vol. 19 Issue 2, p131 

    We report a case of HIV-1 infection transmission caused by a fist fight between brothers. A 30-year-old Caucasian UK resident man developed 'flu-like illness with symptoms of lethargy and weakness. Persistent lymphadenopathy six months later lead to HIV antibody testing, which was positive. Of...

  • Colon Exam Finds Possible Trouble Spots in 60% With HIV.  // HIV Treatment ALERTS!;Apr2012, p24 

    The article presents a study which aims to assess colonoscopy rates in HIV-positive people. It mentions that people with abnormal colon cell results in laboratory studies did not differ from those with normal colon cell results in gender, age, HIV transmission risk, years of antiretroviral...

  • The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection. Calitri, Carmelina; Gabiano, Clara; Galli, Luisa; Chiappini, Elena; Giaquinto, Carlo; Buffolano, Wilma; Genovese, Orazio; Esposito, Susanna; Bernardi, Stefania; De Martino, Maurizio; Tovo, Pier-Angelo // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background In the Highly Active Antiretroviral Therapy (HAART) era, the prognosis of children perinatally infected with HIV-1 has significantly improved, so the number of perinatallyinfected females entering child-bearing age and experiencing motherhood is increasing. Methods A description of...

  • PARTNER: Low risk for HIV transmission through unprotected sex.  // Infectious Disease News;Apr2014, Vol. 27 Issue 4, p38 

    The article discusses a study, led by Jens Lundgren and presented at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, Massachusetts, which suggests that an HIV-positive person on antiretroviral therapy (ART) with suppressed viral load is not sexually infectious.

  • HIV breakthrough.  // New Scientist;5/21/2011, Vol. 210 Issue 2813, p5 

    The article discusses results of a study that suggests antiretroviral therapy (ART) given to HIV-positive individuals before they developed symptoms did not seem to spread the virus to their uninfected partners.

  • Age-Old Questions: When to Start Antiretroviral Therapy and in Whom? Walensky, Rochelle P.; Hirsch, Martin S. // Clinical Infectious Diseases;10/1/2015, Vol. 61 Issue 7, p1196 

    The authors discuss the confusion among physicians over when to start antiretroviral therapy (ART) in cases of in human immunodeficiency virus (HIV) infections. Topics discussed include association of death rates with deferred ART, public health advantages of early ART, and the benefit of early...

  • HIV-1 RNA May Decline More Slowly in Semen than in Blood following Initiation of Efavirenz-Based Antiretroviral Therapy. Graham, Susan M.; Holte, Sarah E.; Dragavon, Joan A.; Ramko, Kelly M.; Mandaliya, Kishor N.; McClelland, R. Scott; Peshu, Norbert M.; Sanders, Eduard J.; Krieger, John N.; Coombs, Robert W.; Lama, Javier R. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Objectives: Antiretroviral therapy (ART) decreases HIV-1 RNA levels in semen and reduces sexual transmission from HIV-1- infected men. Our objective was to study the time course and magnitude of seminal HIV-1 RNA decay after initiation of efavirenz-based ART among 13 antiretroviral-naïve...

  • Current perspectives in HIV post-exposure prophylaxis. Sultan, Binta; Benn, Paul; Waters, Laura // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p147 

    The incidence of human immunodeficiency virus (HIV) infection continues to rise among core groups and efforts to reduce the numbers of new infections are being redoubled. Post-exposure prophylaxis (PEP) is the use of short-term antiretroviral therapy (ART) to reduce the risk of acquisition of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics